Skip to main content
. 2020 Jul 15;11:3548. doi: 10.1038/s41467-020-17178-5

Fig. 5. Longitudinal transcriptional analysis of infants with cCMV infection.

Fig. 5

a The symptomatic biosignature (2592 transcripts) was applied to symptomatic cCMV-infected infants with samples collected at initial testing (n = 23), 1 year (n = 16), 2 years (n = 12) and 3 years (n = 9) of follow-up. b The asymptomatic cCMV biosignature (3324 transcripts) was also applied to asymptomatic cCMV infants with samples collected at initial testing (n = 15), 1 year (n = 9), 2 years (n = 8), and 3 years (n = 4) of follow-up. Transcripts were organized in a heatmap format where each row represents a transcript and each column represents a patient sample. Red color indicates overexpression and blue color underexpression of a transcript compared with the median expression of healthy controls (yellow).